This HTML5 document contains 63 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q90601547
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована 21 жовтня 2019 scientific article published on 21 October 2019 wetenschappelijk artikel artículu científicu espublizáu n'ochobre de 2019
p:P577
wds:Q90601547-0BDF9D61-29FA-470C-A303-E1A355BCB9AE
wdt:P577
2019-10-21T00:00:00Z
p:P2093
wds:Q90601547-AEC9A262-E6D3-468E-A859-5F493717CC0E wds:Q90601547-A0A39948-E21D-4143-B4DA-6342DD358F9F wds:Q90601547-5D4A3A03-6BD3-4E52-8451-8A272A8A2359
wdt:P2093
Farhad Ravandi Wei Qiao Nitin Jain
rdfs:label
Philadelphia chromosome-positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors Philadelphia chromosome-positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors
skos:prefLabel
Philadelphia chromosome-positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors Philadelphia chromosome-positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors
schema:name
Philadelphia chromosome-positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors Philadelphia chromosome-positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors
p:P50
wds:Q90601547-8054A9DF-FD84-40D3-9965-42160F7B6606 wds:Q90601547-8F481970-1C7B-4036-9310-8DDB04AD5219 wds:Q90601547-8F46694A-BD09-48BB-9A56-45427F2AAAEB wds:Q90601547-6DFA82CD-09EF-437C-804B-30B6FC94CD75 wds:Q90601547-73BCE48D-CA4B-497F-B2A6-70681549BF2E wds:Q90601547-D6961112-C8D7-4085-B817-BE9EC3B39EC4 wds:Q90601547-96178119-AAD2-4823-8941-F4A5E5CDFE02 wds:Q90601547-5E93975E-6075-47BF-B418-CBEE2D922B9D wds:Q90601547-6AC9D41C-B273-462B-B181-FA56C0B26DD1 wds:Q90601547-68581D64-4F0E-4615-9442-6FEA6DD08F22 wds:Q90601547-2E170D2C-33D2-4411-BF31-8EBA22383050
wdt:P50
wd:Q87641766 wd:Q87633434 wd:Q42365103 wd:Q104745054 wd:Q60320900 wd:Q90011981 wd:Q89564940 wd:Q114427906 wd:Q60394812 wd:Q66385413 wd:Q88337925
p:P1476
wds:Q90601547-F0C0B611-0F0F-449D-B620-87D2C2520D10
wdt:P1476
Philadelphia chromosome-positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors
p:P304
wds:Q90601547-0C873F81-7A72-464B-8702-4B08B6C6FA8E
wdt:P304
1388-1395
p:P31
wds:Q90601547-73c5bbbe-9f83-447e-824b-d709f059dd0b wds:Q90601547-359286F0-8F53-4693-900D-17AEB9B6E2FE
wdt:P31
wd:Q7318358 wd:Q13442814
p:P921
wds:Q90601547-1CF9F97B-C432-4FE4-8820-F634813E0E13
wdt:P921
wd:Q18553852
p:P698
wds:Q90601547-1CF57815-32C8-4E3A-8AE4-6C7BAFC6E113
wdtn:P698
n11:31595534
wdt:P698
31595534
p:P1433
wds:Q90601547-A4D468E1-D322-4FB2-9397-FB85D68A19E3
wdt:P1433
wd:Q4744246
p:P433
wds:Q90601547-89C695BB-5CF8-4E2A-94F2-FAE607D874D3
p:P478
wds:Q90601547-6EECF9B2-6E43-4142-8E6B-89746BFBF8E9
wdt:P433
12
wdt:P478
94
p:P356
wds:Q90601547-AE4C060C-B23B-4A30-AA3B-FD2018E6CFE5
wdtn:P356
n12:AJH.25648
wdt:P356
10.1002/AJH.25648